148 related articles for article (PubMed ID: 32067504)
41. Passive and iontophoretic transdermal penetration of methotrexate.
Alvarez-Figueroa MJ; Delgado-Charro MB; Blanco-Méndez J
Int J Pharm; 2001 Jan; 212(1):101-7. PubMed ID: 11165825
[TBL] [Abstract][Full Text] [Related]
42. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
Abla N; Naik A; Guy RH; Kalia YN
J Control Release; 2005 Nov; 108(2-3):319-30. PubMed ID: 16169627
[TBL] [Abstract][Full Text] [Related]
43. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis.
Volpato NM; Santi P; Colombo P
Pharm Res; 1995 Nov; 12(11):1623-7. PubMed ID: 8592660
[TBL] [Abstract][Full Text] [Related]
44. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
45. Alteration of electroosmotic volume flow through skin by polyethylene glycols.
Lee SY; Oh SY
Arch Pharm Res; 2015 Jul; 38(7):1397-405. PubMed ID: 25331332
[TBL] [Abstract][Full Text] [Related]
46. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the iontophoretic permselectivity properties of human and pig skin.
Marro D; Guy RH; Delgado-Charro MB
J Control Release; 2001 Jan; 70(1-2):213-7. PubMed ID: 11166421
[TBL] [Abstract][Full Text] [Related]
48. Effect of Combination of Low-Frequency Sonophoresis or Electroporation with Iontophoresis on the Mannitol Flux or Electroosmosis through Excised Skin.
Tokumoto S; Higo N; Todo H; Sugibayashi K
Biol Pharm Bull; 2016; 39(7):1206-10. PubMed ID: 27374295
[TBL] [Abstract][Full Text] [Related]
49. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
[TBL] [Abstract][Full Text] [Related]
50. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
Malinovskaja K; Laaksonen T; Hirvonen J
Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
[TBL] [Abstract][Full Text] [Related]
51. In-vitro characterization of buccal iontophoresis: the case of sumatriptan succinate.
Telò I; Tratta E; Guasconi B; Nicoli S; Pescina S; Govoni P; Santi P; Padula C
Int J Pharm; 2016 Jun; 506(1-2):420-8. PubMed ID: 27113869
[TBL] [Abstract][Full Text] [Related]
52. Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis.
Akomeah FK; Martin GP; Brown MB
Int J Pharm; 2009 Feb; 367(1-2):162-8. PubMed ID: 18950696
[TBL] [Abstract][Full Text] [Related]
53. Transdermal delivery of peptides by iontophoresis.
Hirvonen J; Kalia YN; Guy RH
Nat Biotechnol; 1996 Dec; 14(13):1710-3. PubMed ID: 9634857
[TBL] [Abstract][Full Text] [Related]
54. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia.
Gelfuso GM; Gratieri T; Delgado-Charro MB; Guy RH; Vianna Lopez RF
J Pharm Sci; 2013 May; 102(5):1488-94. PubMed ID: 23450524
[TBL] [Abstract][Full Text] [Related]
55. Iontophoresis promotes percutaneous absorption of L-ascorbic acid in rat skin.
Ebihara M; Akiyama M; Ohnishi Y; Tajima S; Komata K; Mitsui Y
J Dermatol Sci; 2003 Sep; 32(3):217-22. PubMed ID: 14507447
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.
Kalaria DR; Singhal M; Patravale V; Merino V; Kalia YN
Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356
[TBL] [Abstract][Full Text] [Related]
57. NO Exchange for a Water Molecule Favorably Changes Iontophoretic Release of Ruthenium Complexes to the Skin.
de Santana DC; Dias K; Souza JG; Ogunjimi AT; Souza MC; Silva RS; Lopez RF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28075339
[TBL] [Abstract][Full Text] [Related]
58. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
59. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
60. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude.
Yan G; Xu Q; Anissimov YG; Hao J; Higuchi WI; Li SK
Pharm Res; 2008 Mar; 25(3):616-24. PubMed ID: 17703345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
